NL8103626A - Injekteerbare farmaceutische preparaten. - Google Patents

Injekteerbare farmaceutische preparaten. Download PDF

Info

Publication number
NL8103626A
NL8103626A NL8103626A NL8103626A NL8103626A NL 8103626 A NL8103626 A NL 8103626A NL 8103626 A NL8103626 A NL 8103626A NL 8103626 A NL8103626 A NL 8103626A NL 8103626 A NL8103626 A NL 8103626A
Authority
NL
Netherlands
Prior art keywords
acid
preparation according
phenothiazine
carrier
glyceride
Prior art date
Application number
NL8103626A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8103626A publication Critical patent/NL8103626A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8103626A 1980-08-04 1981-07-31 Injekteerbare farmaceutische preparaten. NL8103626A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/174,817 US4297353A (en) 1980-08-04 1980-08-04 Non-irritating injectable dosage forms
US17481780 1980-08-04

Publications (1)

Publication Number Publication Date
NL8103626A true NL8103626A (nl) 1982-03-01

Family

ID=22637640

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8103626A NL8103626A (nl) 1980-08-04 1981-07-31 Injekteerbare farmaceutische preparaten.

Country Status (16)

Country Link
US (1) US4297353A (fr)
JP (1) JPS5758614A (fr)
AU (1) AU7318381A (fr)
BE (1) BE889785A (fr)
DE (1) DE3128579A1 (fr)
DK (1) DK345681A (fr)
ES (1) ES504517A0 (fr)
FI (1) FI812369L (fr)
FR (1) FR2487675A1 (fr)
GB (1) GB2087232A (fr)
IL (1) IL63486A0 (fr)
IT (1) IT1171422B (fr)
NL (1) NL8103626A (fr)
PT (1) PT73466B (fr)
SE (1) SE8104657L (fr)
ZA (1) ZA815356B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
US6960346B2 (en) * 2002-05-09 2005-11-01 University Of Tennessee Research Foundation Vehicles for delivery of biologically active substances
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194733A (en) * 1961-04-26 1965-07-13 Olin Mathicson Chemical Corp Phenothiazine compositions and method of treating mental disorders

Also Published As

Publication number Publication date
DK345681A (da) 1982-02-05
JPS5758614A (en) 1982-04-08
FR2487675A1 (fr) 1982-02-05
DE3128579A1 (de) 1982-08-19
GB2087232A (en) 1982-05-26
AU7318381A (en) 1982-03-11
PT73466A (en) 1981-09-01
IT1171422B (it) 1987-06-10
PT73466B (en) 1983-02-08
IT8149006A0 (it) 1981-07-29
SE8104657L (sv) 1982-02-05
ZA815356B (en) 1983-03-30
ES8401721A1 (es) 1983-05-01
BE889785A (fr) 1982-01-29
ES504517A0 (es) 1983-05-01
US4297353A (en) 1981-10-27
FI812369L (fi) 1982-02-05
IL63486A0 (en) 1981-11-30

Similar Documents

Publication Publication Date Title
DE69929313T2 (de) Verfahren und zusammensetzungen zur verabreichung von taxanen
RU2128505C1 (ru) Фармацевтическая композиция с липидной системой
DE60118395T2 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung für die parenterale applikation von hydrophilen wirkstoffen
RU2100030C1 (ru) Водная суспензия, содержащая микрокристаллы фармакологически активного водонерастворимого лекарственного вещества, покрытые мембранообразующим липидом (варианты), и лиофилизированный препарат водной суспензии
EP0650721B1 (fr) Capsule molle à base de cyclosporine
CN102046192A (zh) GnRH相关化合物的组合物及制备方法
EP2155252B1 (fr) Mélange polymère-lipide injectable permettant une délivrance localisée de médicament
EP0500602B1 (fr) Agent de neutralisation de l'activite procoagulante associee aux cellules tumorales
CA2056445A1 (fr) Composition de clarithromycine injectable
KR0132439B1 (ko) 항암활성 증강제
KR950000770B1 (ko) 경비(輕鼻) 투여용 칼시토닌 함유유제
DE69525740T2 (de) Spezielle halofantrinhaltige Zusammensetzungen
CN1962683A (zh) 聚乙二醇修饰的甾醇共聚物及其应用
WO2008042841A2 (fr) Compositions du docétaxel
NL8103626A (nl) Injekteerbare farmaceutische preparaten.
KR20040068308A (ko) 아제티딘 유도체를 기본으로 하는 약제학적 조성물
JP2003503339A (ja) 抗癌剤を含有する自己乳化システム
DE69329430T2 (de) Konvertierbare mikroemulsionsformulierungen
WO2003057193A1 (fr) Compositions de monoterpene et leurs utilisations
US6288113B1 (en) Angiogenesis promoters
CN111012734B (zh) 一种载药网状原位相变凝胶缓释系统及其制备方法
KR20150000405A (ko) 난용성 의약품의 수중유적형 에멀젼 조성물 및 이의 제조방법
BG64641B1 (bg) Използване на производни на каптотецин с намалена стомашно-чревна токсичност
JPH07196510A (ja) 鎮痛薬含有注射用徐放性脂肪乳剤
JP4804702B2 (ja) アムホテリシンb構造化エマルション

Legal Events

Date Code Title Description
BV The patent application has lapsed